共 7 条
- [5] A Randomized Study of the Relative Pharmacokinetics, Pharmacodynamics, and Safety of Alirocumab, a Fully Human Monoclonal Antibody to PCSK9, After Single Subcutaneous Administration at Three Different Injection Sites in Healthy Subjects [J]. CARDIOVASCULAR THERAPEUTICS, 2014, 32 (06) : 297 - 301
- [6] Pharmacodynamics, pharmacokinetics, safety and tolerability of the novel dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 agonist RG7697 after single subcutaneous administration in healthy subjects [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (10): : 1446 - 1453